Bacteriostatic Reconstitution Water (BAC) · Research brief

BAC Water Dosage Protocol Guide — Reconstitution Standards

Real Peptides Research TeamEditorial

Updated April 13, 20268 min read

60 WORDS

Short answer

Research from compounding pharmacies processing over 12,000 peptide vials annually found that dosage calculation errors. Not contamination or storage failures. Account for nearly 60% of reported reconstitution issues. The error isn't in the sterile technique. It's in the math. Researchers add bacteriostatic water without calculating final peptide concentration, then discover their target dose requires either uncomfortably large injection volumes or…

Key takeaways

Bacteriostatic water dosage for peptide reconstitution should be calculated backward from your target injection volume, not forward from vial size. Most protocols use 2ml BAC water per 5mg vial to achieve 0.2–0.3ml injection volumes.
Benzyl alcohol concentration in BAC water remains bacteriostatic at 0.6% minimum, meaning dilution up to 5ml per vial doesn't compromise 28-day sterility when refrigerated at 2–8°C.
Injection volumes below 0.1ml introduce measurement variability exceeding ±15% with standard insulin syringes. Reconstitute to keep doses in the 0.15–0.4ml range for subcutaneous administration.
Peptides dosed in the 100–1000mcg range require 2ml BAC water per 5mg vial to create 2.5mg/ml solutions, while higher-dose peptides (5–10mg per administration) use 2ml per 10mg vial for the same concentration.
Fragile peptides with short half-lives in solution benefit from more concentrated reconstitution (1ml BAC water per 5mg) to minimise oxidative degradation surface area, while stable synthetic peptides tolerate broader dilution.

Our team has guided hundreds of research facilities through peptide reconstitution protocols. The gap between doing it right and doing it wrong comes down to three things most procedural guides never mention: calculating backward from your target injection volume, accounting for peptide mass versus labeled potency, and understanding why benzyl alcohol concentration matters for multi-dose vial stability.

What is the correct BAC water dosage protocol for peptide reconstitution?

Bacteriostatic water dosage for peptide reconstitution ranges from 0.5ml to 3ml per vial depending on peptide concentration, target dose per injection, and preferred injection volume. The standard research protocol uses 2ml BAC water for a 5mg peptide vial, yielding 2.5mg/ml concentration. Allowing precise dosing in the 0.1–0.4ml injection range with a 0.5ml or 1ml insulin syringe.

The Reconstitution Calculation Most Protocols Skip

Bacteriostatically preserved water isn't just a diluent. It's the variable that determines whether your peptide concentration allows practical dosing. Add 1ml of BAC water to a 5mg peptide vial and you create a 5mg/ml solution. That sounds concentrated and efficient until you realise a 250mcg research dose now requires drawing 0.05ml. A volume so small that the meniscus margin of error in a standard insulin syringe exceeds the dose itself.

The correct BAC water dosage protocol starts with your target injection volume, not your vial size. Most researchers find 0.2–0.3ml the optimal injection volume: large enough for accurate syringe measurement, small enough to avoid subcutaneous discomfort. Work backward from there. If your protocol calls for 250mcg per dose and you want that dose in 0.25ml, you need a final concentration of 1mg/ml. Which means adding 5ml BAC water to a 5mg vial.

Benzyl alcohol. The bacteriostatic agent in BAC water. Maintains antimicrobial efficacy at 0.9% concentration. Standard pharmaceutical BAC water contains 0.9% benzyl alcohol, meaning every millilitre added to your vial introduces 9mg of preservative. Multi-dose vials remain sterile for 28 days at refrigerated temperature as long as benzyl alcohol concentration stays above 0.6%. Diluting a 5mg peptide with 10ml BAC water doesn't compromise sterility. But it does mean each 0.25ml dose now contains only 125mcg, requiring injection volume adjustments.

Peptide-Specific Dosage Standards and Volume Ranges

Different peptide classes require different BAC water dosage protocols because their therapeutic ranges vary by three orders of magnitude. A growth hormone secretagogue like MK 677 might use 10–25mg per dose, while a nootropic peptide such as Dihexa operates in the 1–5mg range. Thymic peptides like Thymalin require microdosing in the 100–500mcg range. The concentration you create during reconstitution determines whether your injection volume is practical.

For peptides dosed in the 1–10mg range, 2ml BAC water per 10mg vial is the research standard. This yields a 5mg/ml solution where a 2.5mg dose = 0.5ml injection volume. Easily measured with a standard 1ml insulin syringe graduated in 0.01ml increments. For peptides dosed in the 100–1000mcg range, 2ml BAC water per 5mg vial creates a 2.5mg/ml solution where a 500mcg dose = 0.2ml. The sweet spot for subcutaneous administration comfort and measurement accuracy.

The peptide's molecular stability in aqueous solution also constrains dilution limits. Fragile peptides like Cerebrolysin. A mixture of low-molecular-weight neuropeptides. Undergo faster degradation at lower concentrations because dilution increases surface area exposure to oxidative stress. These compounds benefit from more concentrated reconstitution: 1ml BAC water per 5ml ampule rather than 2–3ml. Conversely, highly stable synthetic peptides such as CJC1295 Ipamorelin tolerate broader dilution ranges without potency loss over the 28-day use window.

Why Injection Volume Determines Your BAC Water Dosage Protocol

The single most common reconstitution mistake isn't adding too much or too little bacteriostatic water. It's failing to calculate what injection volume your target dose will require after mixing. Researchers assume 'more concentrated is better' and add minimal BAC water, then discover their dose requires drawing 0.03ml with a syringe graduated to 0.01ml. The measurement error margin exceeds the dose itself.

Subcutaneous injection volumes above 0.5ml cause discomfort, visible subcutaneous swelling, and slower absorption due to localised pressure in the injection depot. Volumes below 0.1ml approach the lower measurement limit of standard insulin syringes. Even 0.5ml syringes with 0.01ml graduations introduce ±15% measurement variability at volumes under 0.08ml. The practical injection range is 0.15–0.4ml for most peptide research protocols.

Work through this example using Tesofensine, a monoamine reuptake inhibitor dosed at 500mcg per administration. If you add 1ml BAC water to a 5mg vial, you create a 5mg/ml solution. Meaning your 500mcg dose requires 0.1ml injection volume. Measurement error at this volume runs 10–15%. Now recalculate with 2ml BAC water: you create a 2.5mg/ml solution where 500mcg = 0.2ml. Well within the accurate measurement range and comfortable injection volume. The peptide mass hasn't changed. Your measurement precision has.

Comparison: BAC Water Volumes and Resulting Concentrations

Vial Size	BAC Water Added	Final Concentration	250mcg Dose Volume	500mcg Dose Volume	1mg Dose Volume	Measurement Precision
5mg	1ml	5mg/ml	0.05ml	0.1ml	0.2ml	Poor below 0.1ml. High variability
5mg	2ml	2.5mg/ml	0.1ml	0.2ml	0.4ml	Good. Optimal range for 0.5ml syringe
5mg	3ml	1.67mg/ml	0.15ml	0.3ml	0.6ml	Excellent for microdosing but requires larger total volume
10mg	2ml	5mg/ml	0.05ml	0.1ml	0.2ml	Poor for microdosing protocols
10mg	4ml	2.5mg/ml	0.1ml	0.2ml	0.4ml	Optimal for most research applications

What If: BAC Water Dosage Scenarios

What if I need to dose 150mcg but my vial is 5mg?

Add 2.5ml BAC water to create a 2mg/ml solution where 150mcg = 0.075ml. This is below the ideal measurement range. Consider instead adding 5ml to create 1mg/ml, making your 150mcg dose = 0.15ml. The larger total volume means more injections per vial, but measurement precision improves significantly. Alternatively, if your protocol allows, adjust dosing to 200mcg and use the 2ml reconstitution standard where 200mcg = 0.08ml.

What if I accidentally added 3ml instead of 2ml BAC water?

Your peptide concentration is now 33% lower than intended. A 5mg vial with 3ml BAC water yields 1.67mg/ml instead of 2.5mg/ml. Do not attempt to remove excess liquid or add more peptide powder. Instead, recalculate your injection volumes: if your target dose was 500mcg at 0.2ml (2.5mg/ml), you now need 0.3ml to deliver the same 500mcg from the 1.67mg/ml solution. Mark the vial clearly with the actual concentration to prevent dosing errors.

What if the peptide powder doesn't fully dissolve after adding BAC water?

Incomplete dissolution indicates either insufficient BAC water volume or the peptide requires gentle agitation. Never shake lyophilised peptides. This denatures protein structure. Instead, roll the vial gently between your palms for 30–60 seconds, then refrigerate for 15 minutes and inspect again. If visible particles remain, the issue is likely peptide aggregation from improper lyophilisation or storage. Do not use the vial. Contact the supplier for replacement.

The Unfiltered Truth About BAC Water Dosage Protocols

Here's the honest answer: most reconstitution guides tell you to 'add 2ml bacteriostatic water' without explaining why, and that's where errors start. The 2ml standard exists because it creates peptide concentrations in the range where subcutaneous injection volumes (0.2–0.4ml) align with practical dosing for the majority of research peptides. Not because 2ml is inherently correct for every vial.

If your peptide requires microdosing in the 50–200mcg range, 2ml BAC water per 5mg vial forces you into injection volumes under 0.1ml where measurement error exceeds acceptable variance. You need 5ml to bring doses into the measurable range. Conversely, if you're dosing 5–10mg per injection, 2ml per 10mg vial means injecting 1–2ml per dose. Well above the comfortable subcutaneous limit. You need a more concentrated solution, which means less BAC water.

The calculation is simple: decide your target injection volume first (0.2–0.3ml is optimal), calculate the concentration required to deliver your dose in that volume, then determine how much BAC water achieves that concentration. Work backward from practical administration, not forward from vial markings.

Storage and Stability After Reconstitution

Once you've added bacteriostatic water to a lyophilised peptide, the stability clock starts. Benzyl alcohol prevents microbial growth for 28 days under refrigeration, but it does nothing to prevent peptide degradation from oxidation, temperature fluctuations, or light exposure. Most reconstituted peptides retain 90–95% potency for 14 days at 2–8°C, dropping to 80–85% by day 28. Peptides containing methionine or cysteine residues. Both prone to oxidation. Degrade faster.

Store reconstituted vials upright in the refrigerator's main compartment, not the door. Door storage exposes vials to temperature swings every time the refrigerator opens. Wrap the vial in aluminium foil if the peptide is light-sensitive. Many are, even if the supplier didn't specify. Do not freeze reconstituted peptides unless the manufacturer explicitly states freeze-thaw stability. Most peptides form aggregates during freezing that don't redissolve upon thawing.

If you're working with peptides like Survodutide or Mazdutide. Both dual GLP-1/GIP agonists requiring precise dosing. Mark each vial with reconstitution date, final concentration, and expiration date (28 days from mixing). Use a laboratory-grade marker that won't smudge when wet. Discard any vial past 28 days regardless of appearance. Benzyl alcohol efficacy drops below the bacteriostatic threshold, and bacterial contamination risk increases sharply.

Bacteriostatic water itself remains sterile for 28 days after first puncture when refrigerated. Unopened vials stored at room temperature maintain sterility until the printed expiration date. Typically 2–3 years from manufacture. Once opened, refrigerate and use within 28 days. Do not use BAC water that appears cloudy, discoloured, or contains visible particles.

Our commitment to research-grade quality extends across every peptide we supply. Whether you're working with Cartalax for cellular research, Hexarelin for growth hormone studies, or newer compounds like SLU PP 332, proper reconstitution technique determines whether the peptide's documented bioactivity translates into reproducible research outcomes. The margin between precision and guesswork is smaller than most protocols acknowledge. And it starts with understanding that BAC water dosage isn't a fixed number. It's a calculation tailored to your specific peptide, your target dose, and the injection volume that makes accurate measurement possible.

The information in this BAC water dosage protocol guide is for research and educational purposes. Dosage calculations and reconstitution decisions should be made following established laboratory protocols and, where applicable, under the supervision of qualified research personnel.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Add 2ml bacteriostatic water to a 5mg peptide vial to create a 2.5mg/ml solution — this concentration allows most research doses to fall in the 0.2–0.4ml injection range, which is optimal for accurate measurement with standard insulin syringes and comfortable subcutaneous administration. If your protocol requires microdosing below 200mcg per injection, increase to 5ml BAC water to create a 1mg/ml solution where smaller doses remain measurable.

Yes, you can add up to 5ml bacteriostatic water per 5mg vial without compromising sterility — the benzyl alcohol concentration remains above the 0.6% bacteriostatic threshold even at higher dilutions. Higher dilution is beneficial for microdosing protocols where target doses fall below 250mcg, as it brings injection volumes into the 0.15–0.3ml range where syringe measurement accuracy improves significantly. The trade-off is fewer total doses per vial.

Adding insufficient bacteriostatic water creates an overly concentrated solution that forces your target dose into uncomfortably small injection volumes — often below 0.1ml where measurement error with standard syringes exceeds ±15%. This introduces significant dosing variability and makes accurate administration nearly impossible. You cannot add more BAC water after initial reconstitution without risking contamination, so the vial must be used at the higher concentration with recalculated injection volumes.

Reconstituted peptides in bacteriostatic water remain sterile for 28 days when stored at 2–8°C, as benzyl alcohol maintains antimicrobial efficacy throughout this period. However, peptide potency typically degrades to 80–85% of original concentration by day 28 due to oxidation and hydrolysis — most peptides retain 90–95% potency through day 14. Discard any vial past 28 days regardless of appearance, as bacterial contamination risk increases once benzyl alcohol concentration drops below the bacteriostatic threshold.

Yes — bacteriostatic water contains 0.9% benzyl alcohol as a preservative, allowing multi-dose use for up to 28 days, while sterile water contains no preservative and must be used immediately after opening or discarded. For research protocols requiring multiple draws from a single vial over days or weeks, bacteriostatic water is the standard choice. Sterile water is appropriate only for single-use applications where the entire vial contents will be drawn and used within hours of reconstitution.

Aim for a final peptide concentration that delivers your target dose in 0.2–0.3ml injection volume — this range optimises measurement accuracy and subcutaneous administration comfort. For most research peptides, this means 2–2.5mg/ml concentration: use 2ml BAC water per 5mg vial or 4ml per 10mg vial. Microdosing protocols requiring 100–250mcg per injection benefit from lower concentrations (1mg/ml), while high-dose protocols above 5mg per injection require more concentrated solutions to avoid multi-millilitre injection volumes.

Transferring reconstituted peptide between vials introduces contamination risk and is not recommended for research-grade work. Each transfer breaks sterility, and even with aseptic technique, bacterial or fungal contamination becomes increasingly likely with each additional manipulation. If you need smaller aliquots, reconstitute the peptide in a single vial and draw individual doses as needed — this maintains the bacteriostatic protection of the sealed vial throughout the 28-day use period.

Peptide-specific BAC water dosage protocols vary because therapeutic dose ranges differ by orders of magnitude — a growth factor dosed at 5–10mg per injection requires different concentration than a neuropeptide dosed at 100–500mcg. Additionally, some peptides degrade faster in dilute solution due to increased oxidative surface area exposure, necessitating more concentrated reconstitution for stability. The optimal BAC water volume is determined by your target dose, preferred injection volume, and the peptide’s molecular stability profile in aqueous solution.

Cloudiness or visible particles after reconstitution indicate either incomplete dissolution, peptide aggregation from improper storage, or contamination. Do not shake the vial — instead, roll it gently between your palms for 30–60 seconds and refrigerate for 15 minutes. If particles persist, the peptide has likely degraded or aggregated during lyophilisation or storage and should not be used. Contact the supplier for replacement — properly lyophilised peptides dissolve completely in bacteriostatic water within 2–3 minutes of gentle agitation.

Divide your target dose in milligrams by the final concentration in mg/ml — this gives injection volume in millilitres. Example: if you reconstituted a 5mg vial with 2ml BAC water (creating 2.5mg/ml) and your target dose is 500mcg (0.5mg), the calculation is 0.5mg ÷ 2.5mg/ml = 0.2ml injection volume. Always convert micrograms to milligrams before dividing (divide mcg by 1000), and verify your calculation matches practical syringe graduations before drawing the dose.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA